Hosted by the Institute of Clinical and Translational Sciences (ICTS) and the WashU School of Medicine

To RSVP, please contact Carol Sharp.

Agenda – Program Outline

12:00p    Introduction and lunch

12:30p    Keynote presentation  John DiPersio (WashU Medicine) – “Building a Career in Oncology”

1:15p    Felicia Gomez (WashU Medicine) – “Ultra-deep Sequencing of Classical Hodgkin lymphoma (cHL) Reveals Novel Somatic Mutations and Exemplifies the Utility of Deep Sequencing in the Characterization of Rare Malignant Cells”

1:35p    Tanner Johanns (WashU Medicine) – “Identification of Novel Immunogenic Targets for the Treatment of Glioblastoma”

1:55p    Michael Alberti (WashU Pathology & Immunology) – “Mutant U2AF1S34F and U2AF1Q157P/R Induce Distinct RNA Splicing and Hematopoietic Phenotypes in Vivo”

2:15p    Break

2:30p    Francesca Ferraro (WashU Medicine) – “The Molecular Basis of Favorable Risk AML”

2:50p    Jeffrey Ward (WashU Medicine) – “Remodeling of Intratumoral Lymphoid and Myeloid Compartments by Effective Cancer Immunotherapies”

3:10p    Todd Fehniger (WashU Medicine) – “Getting Funded: Do’s and Don’ts”

Reception immediately following in the EPNEC Lobby Area.